ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.
Condition: Breast CancerIntervention: Drug: EribulinSponsor: Imperial College LondonRecruiting - verified January 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Research | Study